Senate narrows felony‑homicide change tied to drug deaths; committee substitute approved 21‑19

The Virginia Senate on Feb. 3, 2025, approved a committee substitute to a bill addressing felony‑homicide liability in drug‑related deaths. The recorded vote on the committee substitute was 21 in favor and 19 opposed.

Senator McDougall, who introduced the measure in the form debated on the floor, said his original bill would have allowed felony‑homicide prosecution when a person sells or distributes controlled substances that are the proximate cause of another person’s death. He argued the change was intended to prevent drug dealers from continuing to sell dangerous mixes that lead to overdoses.

Members of the courts committee proposed a narrower substitute during committee work. The version the Senate adopted limits the elevated homicide exposure in several ways: it applies specifically to fentanyl when the drug sold or distributed is the sole and proximate cause of death and it focuses on deaths of minors (the committee language applies when the decedent is under a specified age). The substitute also retained or added an accommodation defense in some circumstances and included safe‑harbor language intended to encourage callers to report overdoses without fear of prosecution.

Supporters said the measure targets the exceptional lethality of fentanyl and gives prosecutors a tool when a dealer’s product directly caused a minor’s death. Opponents, including those with experience in criminal law, warned the statute raises proof challenges and could produce prosecutions based on difficult-to-prove links between a sale and a later death, especially when multiple substances may be involved.

The committee substitute passed on a recorded vote, 21‑19; senators then moved to engross the bill in advance to third reading.

Ending: Senators acknowledged further work is possible in conference or future sessions; for now the Senate approved the narrower committee substitute and sent the measure forward in the process.